Hilltop Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Hilltop Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,072	Closed	-$618K	–	937
2025 Q4	$618K	Buy	+5,072	New	+$582K	0.04%	485
2023 Q2	–	Sell	-3,378	Closed	-$257K	–	612
2023 Q1	$257K	Buy	3,378 +303	+10%	+$25.1K	0.03%	435
2022 Q4	$255K	Hold	3,075	–	–	0.03%	427
2022 Q3	$244K	Buy	+3,075	New	+$259K	0.03%	419
2020 Q2	–	Sell	-100	Closed	-$8K	–	425
2020 Q1	$8K	Buy	+100	New	+$8.86K	﹤0.01%	345

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hilltop Holdings's XBI Position: Q1 2026 in Review

Hilltop Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 5,072 shares — an estimated $618K sold.

Hilltop Holdings first reported a position in XBI in Q1 2020 and held it in 5 quarters. The position peaked at $618K in Q4 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Hilltop Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
Hilltop Holdings sold 5,072 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $618K.
Hilltop Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 5 quarters.
Hilltop Holdings's State Street SPDR S&P Biotech ETF position peaked at $618K in Q4 2025.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.